最新高血壓指南的幾个问题.pptVIP

最新高血压指南的几个问题;内容提要;高血压患者危险分层--WHO/ISH 1999;影响高血压患者预后的因素;高血压患者危险分层--2003欧洲高血压指南;血压分类--JNC-VI(1997);1. Distribution of NHANES I Epldemiologic Follow-up Study Participants with a High-Normal BP or Hypertension at Baseline According to BP Lovel and Risk Categorization;2. Estimated Effect of a 12mmHg Reduction in SBP Over 10 years on the Number-Needed-to-Treat to Prevent a Cardiovascular Disease Event Among NHANES I Epidemiologic Follow-Up Study Participants According to Baseline BP Level and Category of Presumed Cardiovascular Risk;3. Estimated Effect of a 12mmHg Reduction in SBP Over 10 years on the Number-Needed-to-Treat to Prevent a Cardiovascular Disease Death Among NHANES I Epidemiologic Follow-Up Study Participants According to Baseline BP Level and Category of Presumed Cardiovascular Risk;4. Estlmated Effect of a 12mmHg Reduction in SBP Over 10 years on the Number-Needed-to-Treat to Prevent An AI-Cause Death Among NHANES I Epidemiologic Follow-Up Study Participants According to Baseline BP Level and Category of Presumed Cardiovascular Risk;不同危险程度高血压患者的血压水平(mmHg, x?s);心血管危险度分层的重要性（一） 高血压常常伴随其它危险因素 降压治疗的目的是减少心血管发病与死亡（CVD Risk）,而不仅是降低血压（RFs)，所以对心血管危险的估算是不可或缺的 血压升高是CVD RR 的重要指标，故以往只看血压水平决定治疗策略。此法对中重度高血压行之有效，对轻度高血压则否 ;心血管危险度分层的重要性（二）;Problems With a Strategy Based on Absolute Cardiovascular RiskF. Olaf Simpson/Journal of Hypertension 1996, Vol 14 No 6;Cardiovascular risk evaluation：an inexact science （1）;Although the absolute risk assessment methods may lack sufficient sensitivity, they still represent an improvement over that only the level of blood pressure and prior cardiovascular disease were relevant to therapeutic-decision making. To date, cardiovascular risk evaluation is an inexact science.;Enhancing risk stratification in hypertensive subjects: How far should we go in routine screening for target organ damage? ;Pharmacological Treatment of HypertensionJ D Swales / The Lancet Vol 344. Aug. 6, 1994;血压水平为正常高值;血压水平为I-II级高血压;内容提要;Interventions evaluated